Found 6 matching trials
Breast Cancer After Ovarian Cancer During and/or After Therapy: Genomic Evaluation
N/AThis study will investigate, in patients with germline BRCA-1/2 mutations a...
Location
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
PHASE1Background:
Blood cancers (such as leukemias) can be hard to treat, especi...
Location
National Institutes of Health Clinical Center
Molecular Subtyping of Triple-negative Breast Cancer and African Ancestry-related Immunogenicity
N/ATriple-negative breast cancer (TNBC) is a heterogeneous disease that is ass...
Location
Nova Scotia Health
Imatinib to Increase RUNX1 Activity in Participants With Germline RUNX1 Deficiency
PHASE1Background:
Runt-related transcription factor 1 (RUNX1) gene regulates the...
Location
National Institutes of Health Clinical Center
A Synthetic Lethality-Focused Algorithm to Identify Therapeutic Options in Advanced Metastatic Breast Cancer (SYNTHESIS-Breast)
NABackground:
Breast cancer is the most common cancer in US women. There are...
Location
National Institutes of Health Clinical Center
A Single-center Prospective Interventional Study on FPG500 in Non-metastatic Prostate Cancer Patients
NAThe search for clinically actionable alterations within the non-metastatic ...
Location
Fondazione Policlinico Universitario A. Gemelli IRCCS, UOC Urologia